Princeton VPs to soon be charged.
Look for charges re: off label promotion, Levulan pricing, and the whole Foundation Care scheme. TG’s on the hook for signing off.
Many other issues - there’s a long list of those going to court.
None of them will get to bunk up with Lori Loughlan though
Sorry Abhay.
Team,
what the hell is the story here. It is end of the year. Christmas is coming. You don’t want anxiety going into a holiday season. Let’s be serious. Can someone provide a background around this?
Is there actually a court case going on? I seriously don’t know so please no silly responses
Team,
what the hell is the story here. It is end of the year. Christmas is coming. You don’t want anxiety going into a holiday season. Let’s be serious. Can someone provide a background around this?
Princeton VPs to soon be charged.
Enjoy the holiday?
Problems (Levulan off label,...) are real big issues. And do not forget the lawsuit from Biofrontera. It could cost a lot of money for DUSA/SUN.... Millions $$$
Yeah they are both legit issues, but there’s at least one other the pales all others combined.
Manzano is aware of it - maybe the heat was getting too close and that’s why he left.
Or he left because he found another job.......Leaving doesn't indemnify him from any issues going on while he was there.
Perhaps he left because it will get worse and he cannot resolve it.
That’s a possibility but unlikely. When you’re as high up on the global food chain (top 10) with Dilip, you don’t walk out the door. Too much to leave on the table.Or he left because he found another job.......
Or he left because he found another job.......
Yeah they are both legit issues, but there’s at least one other the pales all others combined.
Manzano is aware of it - maybe the heat was getting too close and that’s why he left.
There is the one item around generics including Nexium which was recently filed in the Boston courts (public record). And perhaps that’s the one that pushed Manzano off the ledge. That could be a real biggie for Dilip.What is it? The lawsuits (from my point of view they will lost it...). One bigger one??
There is the one item around generics including Nexium which was recently filed in the Boston courts (public record). And perhaps that’s the one that pushed Manzano off the ledge. That could be a real biggie for Dilip.
But there’s another situation, not filed, that I think could be bigger than any of the others.
And now Taro's CFO is resigning to go work at a private firm.That’s a possibility but unlikely. When you’re as high up on the global food chain (top 10) with Dilip, you don’t walk out the door. Too much to leave on the table.